See Correction Below.
By Mandy Jackson Daily Journal Staff Writer P harmaceutical companies are following in the footsteps of the technology industry by pooling patents. But where high-tech patent pools set up to create market standards face charges of anti-competitive activity, the public benefit generated by the Medicines Patent Pool - low cost drugs for developing countries - could help pharmaceutic...
By Mandy Jackson Daily Journal Staff Writer P harmaceutical companies are following in the footsteps of the technology industry by pooling patents. But where high-tech patent pools set up to create market standards face charges of anti-competitive activity, the public benefit generated by the Medicines Patent Pool - low cost drugs for developing countries - could help pharmaceutic...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In